Neurocrine Biosciences shares owned by BlackRock
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.8B | 13M | 140.38 |
| 2025-06-30 | $1.6B | 13M | 125.69 |
| 2025-03-31 | $1.6B | 15M | 110.60 |
| 2024-12-31 | $2.0B | 15M | 136.50 |
| 2024-09-30 | $1.6B | 14M | 115.22 |